Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.44%23.7M | -2.86%23.25M | -18.32%19.36M | -2.07%88.01M | -13.75%20.35M | -16.46%20.01M | 3.89%23.94M | 23.71M | 38.05%89.87M | 23.6M |
| Cost of revenue | -1.08%18.23M | -1.17%18.73M | 0.58%19.15M | 11.64%76.52M | 11.69%20.11M | -2.78%18.42M | 12.90%18.95M | 19.04M | 40.73%68.54M | 18M |
| Gross profit | 244.96%5.48M | -9.28%4.52M | -95.36%217K | -46.13%11.49M | -95.62%245K | -68.27%1.59M | -20.28%4.99M | 4.67M | 30.08%21.33M | 5.59M |
| Operating expense | 47.59%4.32M | 54.01%4.11M | 33.59%3.35M | 11.93%11.44M | 34.68%3.38M | -8.81%2.93M | 8.82%2.67M | 2.51M | 32.62%10.22M | 2.51M |
| Selling and administrative expenses | 47.56%4.32M | 53.23%4.09M | 33.59%3.35M | 11.93%11.44M | 34.68%3.38M | -8.81%2.93M | 8.82%2.67M | --2.51M | 32.65%10.22M | --2.51M |
| -General and administrative expense | 47.56%4.32M | 53.23%4.09M | 33.59%3.35M | 11.93%11.44M | 34.68%3.38M | -8.81%2.93M | 8.82%2.67M | --2.51M | 32.65%10.22M | --2.51M |
| Other operating expenses | --1K | --21K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 186.13%1.16M | -81.99%418K | -244.67%-3.13M | -99.49%57.17K | -201.36%-3.13M | -174.83%-1.34M | -39.02%2.32M | 2.17M | 27.84%11.12M | 3.09M |
| Net non-operating interest income (expenses) | -16.43%-248K | -38.95%-239K | -54.71%-263K | 83.05%-54.39K | -14.36%-223K | -78.99%-213K | 30.08%-172K | -170K | -92.34%-320.95K | -195K |
| Non-operating interest income | ---- | ---- | ---- | 96.28%723.79K | ---- | ---- | ---- | ---- | 89.38%368.76K | ---- |
| Non-operating interest expense | 16.43%248K | 38.95%239K | 54.71%263K | 12.83%778.19K | 14.36%223K | 78.99%213K | -30.08%172K | --170K | 90.74%689.71K | --195K |
| Net investment income | 593.28%55.61K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 133.05%19.5K | -59.01K | ||||||||
| Less:Write off | ---- | ---- | ---- | -133.05%-19.5K | ---- | ---- | ---- | ---- | --59.01K | ---- |
| Other non-operating income (expenses) | -6.22%196K | 60.63%204K | -21.71%220K | -58.65%8.15K | -34.93%177K | 50.36%209K | 746.67%127K | 281K | 159.53%19.71K | 272K |
| Income before tax | 182.01%1.1M | -83.17%383K | -239.50%-3.18M | -99.72%30.42K | -200.35%-3.18M | -174.23%-1.35M | -36.34%2.28M | 2.28M | 26.53%10.81M | 3.17M |
| Income tax | 102.13%91K | -97.79%14K | -98.15%11K | -192.14%-2.98M | -92.47%63K | -601.29%-4.28M | -33.54%634K | 596K | 40.91%3.24M | 837K |
| Net income | -65.47%1.01M | -77.53%369K | -289.64%-3.19M | -60.21%3.01M | -239.13%-3.24M | 205.63%2.93M | -37.35%1.64M | 1.68M | 21.25%7.57M | 2.33M |
| Net income continuous operations | -65.47%1.01M | -77.53%369K | -289.64%-3.19M | -60.21%3.01M | -239.13%-3.24M | 205.63%2.93M | -37.35%1.64M | --1.68M | 21.25%7.57M | --2.33M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -65.47%1.01M | -77.53%369K | -289.64%-3.19M | -60.21%3.01M | -239.13%-3.24M | 205.63%2.93M | -37.35%1.64M | 1.68M | 21.25%7.57M | 2.33M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -65.47%1.01M | -77.53%369K | -289.64%-3.19M | -60.21%3.01M | -239.13%-3.24M | 205.63%2.93M | -37.35%1.64M | 1.68M | 21.25%7.57M | 2.33M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -65.31%0.0017 | -77.78%0.0006 | -300.00%-0.0053 | -66.67%0.008 | -236.73%-0.0054 | 206.25%0.0049 | -38.19%0.0027 | 0.0026 | 130.53%0.024 | 0.0039 |
| Diluted earnings per share | -65.31%0.0017 | -77.78%0.0006 | -300.00%-0.0053 | -66.67%0.008 | -236.73%-0.0054 | 206.25%0.0049 | -38.19%0.0027 | 0.0026 | 130.53%0.024 | 0.0039 |
| Dividend per share | 0.0045 | 0 | 0 | 0.0058 | 0 | 0 | 0.0058 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.